Medicare Enrolled

Dr. Regina Berkovich, MD

Neurology · West Hollywood, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
8727 BEVERLY BLVD STE B, West Hollywood, CA 90048
3104749595
In practice since 2007 (19 years)
NPI: 1881743748 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Berkovich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berkovich? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Berkovich

Dr. Regina Berkovich is a neurology specialist in West Hollywood, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Berkovich performed 27,744 Medicare services across 221 unique beneficiaries.

Between the years covered by Open Payments, Dr. Berkovich received a total of $2,908,996 from 53 pharmaceutical and/or device companies across 3180 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Berkovich is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 3% volume in CA $2,908,996 industry payments

Medicare Practice Summary

Medicare Utilization ↗
27,744
Medicare services
Top 3% in CA for neurology
221
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,460 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, natalizumab, 1 mg 27,000 $19 $60
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
385 $145 $484
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
119 $18 $104
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
115 $59 $254
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
88 $107 $363
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
23 $27 $358
New patient office visit, complex (60-74 min) 14 $181 $682
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
97.3% medium
1.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,908,996
Total received (2018-2024)
Avg $415,571/year across 7 years
Top 0% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
3,180
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,628,878 (90.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$261,308 (9.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,810 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$473,860
2023
$392,529
2022
$426,164
2021
$321,188
2020
$288,573
2019
$515,046
2018
$491,637

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$145,257
Amgen Inc.
$58,439
TG Therapeutics, Inc.
$49,395
Biogen, Inc.
$44,517
Alexion Pharmaceuticals, Inc.
$43,409
E.R. Squibb & Sons, L.L.C.
$30,546
Mallinckrodt Hospital Products Inc.
$29,370
ANI Pharmaceuticals, Inc.
$25,257
GENZYME CORPORATION
$18,186
Ares Trading SA
$10,920
Novartis Pharmaceuticals Corporation
$10,160
Vanda Pharmaceuticals Inc.
$4,865
Celgene Corporation
$2,564
BANNER LIFE SCIENCES, LLC
$142
Acorda Therapeutics, Inc
$134
Sandoz Inc.
$132
UCB, Inc.
$125
Eisai Inc.
$116
Genentech USA, Inc.
$75
CSL Behring
$62
ABBVIE INC.
$55
Grifols USA, LLC
$52
Merz Pharmaceuticals, LLC
$33
Janssen Scientific Affairs, LLC
$31
PFIZER INC.
$19
Top 3 companies account for 53.4% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$835,366
GENZYME CORPORATION
$390,711
EMD Serono, Inc.
$384,883
Novartis Pharmaceuticals Corporation
$183,618
Mallinckrodt Hospital Products Inc.
$172,711
Alexion Pharmaceuticals, Inc.
$148,042
Celgene Corporation
$125,729
E.R. Squibb & Sons, L.L.C.
$111,014
Horizon Therapeutics plc
$77,124
Amgen Inc.
$58,508
TG THERAPEUTICS, INC.
$53,741
Janssen Pharmaceuticals, Inc
$51,207
SANOFI-AVENTIS U.S. LLC
$50,556
TG Therapeutics, Inc.
$49,395
Genentech USA, Inc.
$41,260
ANI Pharmaceuticals, Inc.
$36,407
Mallinckrodt Enterprises LLC
$25,633
Ares Trading SA
$20,799
Banner Life Sciences, LLC
$20,156
Mallinckrodt LLC
$12,274
Acorda Therapeutics, Inc
$10,971
NOVARTIS PHARMACEUTICALS CORPORATION
$10,039
Greenwich Biosciences, Inc.
$9,471
Novartis Pharma AG
$8,259
Vanda Pharmaceuticals Inc.
$4,865
Merck KGaA
$4,600
BANNER LIFE SCIENCES, LLC
$3,722
Bayer HealthCare Pharmaceuticals Inc.
$1,773
Exeltis, USA Inc.
$1,685
Janssen Scientific Affairs, LLC
$1,651
Avanir Pharmaceuticals, Inc.
$824
Grifols USA, LLC
$298
AbbVie Inc.
$216
Otsuka America Pharmaceutical, Inc.
$203
CSL Behring
$161
Sandoz Inc.
$132
Allergan, Inc.
$125
UCB, Inc.
$125
Teva Pharmaceuticals USA, Inc.
$121
Eisai Inc.
$116
ABBVIE INC.
$113
Lundbeck LLC
$90
PFIZER INC.
$68
Allergan Inc.
$37
Merz Pharmaceuticals, LLC
$33
Merz North America, Inc.
$29
Biohaven Pharmaceutical Holding Company Ltd.
$27
Kyowa Kirin, Inc.
$22
Lilly USA, LLC
$19
Biohaven Pharmaceuticals, Inc.
$19
ARBOR PHARMACEUTICALS, INC.
$18
Genentech, Inc.
$17
Abbott Laboratories
$14
Top 3 companies account for 55.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · COPAXONE · EMGALITY · Evobrutinib · FTY720D · GILENYA · Gamunex-C · Hizentra · Horizant · INBRIJA · Infinity DBS Pulse Generators · KESIMPTA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MS DISEASE STATE · Mavenclad · NO PRODUCT DISCUSSED · NOURIANZ · NUEDEXTA · NURTEC ODT · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ocrevus · Ocrevus Zunovo · Ozanimod · PANZYGA · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · Rebif · Rystiggo · SOLIRIS · Soliris · TECFIDERA · TYSABRI · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · VYEPTI · XEOMIN · ZARXIO · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neurology in CA.

Looking for a neurology specialist in West Hollywood?
Compare neurologists in the West Hollywood area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
548
Per 100K population
5.6
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Berkovich is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Berkovich experienced with injection, natalizumab, 1 mg?
Based on Medicare claims data, Dr. Berkovich performed 27,000 injection, natalizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berkovich receive payments from pharmaceutical companies?
Yes. Dr. Berkovich received a total of $2,908,996 from 53 companies across 3,180 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berkovich's costs compare to other neurologists in West Hollywood?
Dr. Berkovich's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berkovich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →